AI assistant
Sending…
Active Biotech — Major Shareholding Notification 2020
Sep 25, 2020
3133_iss_2020-09-25_66fec1f3-b3c1-4d98-b010-00395649232c.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
{# SEO P0-1: filing HTML is rendered server-side so Googlebot
sees the full text without executing JS or following an
iframe to a Disallow'd CDN path. The content has already
been sanitized through filings.seo.sanitize_filing_html. #}

Issuer Active Biotech AB (publ)
Holder
Nordstjernan Aktiebolag
Instrument
| Instrument | Aktie SE0001137985 | |
|---|---|---|
| Before the transaction | ||
| Shares | 15,205,005 | |
| Voting rights | 15,205,005 | |
| Transaction | ||
| Reason for major shareholding notification Sell | ||
| Date | 25/09/2020 | |
| Limit for number of shares | 10 % | |
| Limit for number of votes | 10 % | |
| After the transaction | ||
| Quantity | ||
| Shares | 14,440,158 | |
| Directly held voting rights | 14,440,158 | |
| Indirectly held voting rights | 0 | |
| Percentage | ||
| Directly held shares | 9.94 % | |
| Directly held voting rights | 9.94 % | |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 9.94 % | 14,440,158 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled - Cash settled |
||
| Total | 9.94 % | 14,440,158 |
| Group total holdings |
||
| Voting rights 14,440,158 Percentage of voting rights 9.94 |
||
| Published 25/09/2020 18:25 |
||
| Contact | ||
| Name Mats Liljegren |
||
| Phone 08-788 50 12 Email [email protected] |
||

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Active Biotech
Quarterly Report
2026
May 7
Quarterly Report
2026
May 7
Regulatory Filings
2026
Apr 17
Regulatory Filings
2026
Apr 17
Annual Report (ESEF)
2026
Apr 1
Audit Report / Information
2026
Feb 12
Audit Report / Information
2026
Feb 12
Share Issue/Capital Change
2026
Jan 30
Share Issue/Capital Change
2026
Jan 30
Regulatory Filings
2026
Jan 21